National Risk Distribution

National Risk Distribution company information, Employees & Contact Information

National Risk Distribution South Africa is a specialist brokerage and intermediary. NRD believes in providing our customers with the best quality insurance products on the market. We offer customised and relevant products to our extensive client base by evaluating market trends and needs. As an authorised category 1 FSP, NRDSA is licensed to sell products in respect of the following sub-categories: Long-Term Insurance: Category A, Friendly Society Benefits. NRDSA is a licensed Financial Service Provider in terms of the Financial Advisory and Intermediary Services Act: FSP No. 47486.
Looking for a particular National Risk Distribution employee's phone or email?

National Risk Distribution Questions

News

NRD Cyber Security completes successful phase in Bangladesh and plans to focus on regional expansion - Yahoo! Finance UK

NRD Cyber Security completes successful phase in Bangladesh and plans to focus on regional expansion Yahoo! Finance UK

The first half of 2025 brought NRD Cyber Security a 45% increase in revenue and a strategic shift towards a cybersecurity-as-a-service model - Yahoo! Finance UK

The first half of 2025 brought NRD Cyber Security a 45% increase in revenue and a strategic shift towards a cybersecurity-as-a-service model Yahoo! Finance UK

Development of Standardized NRD Assessments - Mass.gov

Development of Standardized NRD Assessments Mass.gov

Office of Natural Resource Restoration - New Jersey Department of Environmental Protection (.gov)

Office of Natural Resource Restoration New Jersey Department of Environmental Protection (.gov)

Investigating investment in biopharmaceutical R&D - Nature

Investigating investment in biopharmaceutical R&D Nature

News - New CO Takes Helm of NRD Houston - DVIDS

News - New CO Takes Helm of NRD Houston DVIDS

National Resource Directory provides centralized access to information, resources for Veterans - VA News (.gov)

National Resource Directory provides centralized access to information, resources for Veterans VA News (.gov)

Nitrate help in your area: Find your NRD, learn about its resources - Flatwater Free Press

Nitrate help in your area: Find your NRD, learn about its resources Flatwater Free Press

Navigating tax compliance challenges for UK non-resident directors - International Tax Review

Navigating tax compliance challenges for UK non-resident directors International Tax Review

National Resource Directory for Veterans - Military.com

National Resource Directory for Veterans Military.com

Aziz Hashim ‘Humbled’ as NRD Closes Second Franchise Fund - franchisetimes.com

Aziz Hashim ‘Humbled’ as NRD Closes Second Franchise Fund franchisetimes.com

mRNA vaccines — a new era in vaccinology - Nature

mRNA vaccines — a new era in vaccinology Nature

Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis - Nature

Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis Nature

Strategies and challenges for the next generation of antibody–drug conjugates - Nature

Strategies and challenges for the next generation of antibody–drug conjugates Nature

Targeting macrophages: therapeutic approaches in cancer - Nature

Targeting macrophages: therapeutic approaches in cancer Nature

Deubiquitylating enzymes and drug discovery: emerging opportunities - Nature

Deubiquitylating enzymes and drug discovery: emerging opportunities Nature

Trends in GPCR drug discovery: new agents, targets and indications - Nature

Trends in GPCR drug discovery: new agents, targets and indications Nature

Coronaviruses — drug discovery and therapeutic options - Nature

Coronaviruses — drug discovery and therapeutic options Nature

Tracing investment in drug development for Alzheimer disease - Nature

Tracing investment in drug development for Alzheimer disease Nature

Non-invasive delivery strategies for biologics - Nature

Non-invasive delivery strategies for biologics Nature

Induced protein degradation: an emerging drug discovery paradigm - Nature

Induced protein degradation: an emerging drug discovery paradigm Nature

Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations - Nature

Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations Nature

Michael Hanson - Nature

Michael Hanson Nature

Impact of a five-dimensional framework on R&D productivity at AstraZeneca - Nature

Impact of a five-dimensional framework on R&D productivity at AstraZeneca Nature

Kinase inhibitors: the road ahead - Nature

Kinase inhibitors: the road ahead Nature

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases - Nature

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases Nature

Jim O'Neill - Nature

Jim O'Neill Nature

Trends in the global immuno-oncology landscape - Nature

Trends in the global immuno-oncology landscape Nature

CAR-T cells take aim at autoimmunity - Nature

CAR-T cells take aim at autoimmunity Nature

Next generation antibody drugs: pursuit of the 'high-hanging fruit' - Nature

Next generation antibody drugs: pursuit of the 'high-hanging fruit' Nature

Nonalcoholic steatohepatitis (NASH) drugs market - Nature

Nonalcoholic steatohepatitis (NASH) drugs market Nature

Parsing clinical success rates - Nature

Parsing clinical success rates Nature

A dynamic map for learning, communicating, navigating and improving therapeutic development - Nature

A dynamic map for learning, communicating, navigating and improving therapeutic development Nature

The promise and challenges of immune agonist antibody development in cancer - Nature

The promise and challenges of immune agonist antibody development in cancer Nature

Unexplored therapeutic opportunities in the human genome - Nature

Unexplored therapeutic opportunities in the human genome Nature

Biophysics in drug discovery: impact, challenges and opportunities - Nature

Biophysics in drug discovery: impact, challenges and opportunities Nature

The drug–target residence time model: a 10-year retrospective - Nature

The drug–target residence time model: a 10-year retrospective Nature

Alzheimer amyloid hypothesis lives on - Nature

Alzheimer amyloid hypothesis lives on Nature

Aptamers as targeted therapeutics: current potential and challenges - Nature

Aptamers as targeted therapeutics: current potential and challenges Nature

Phase II and phase III failures: 2013–2015 - Nature

Phase II and phase III failures: 2013–2015 Nature

Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design - Nature

Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design Nature

Expanding the medicinal chemistry synthetic toolbox - Nature

Expanding the medicinal chemistry synthetic toolbox Nature

Delivery technologies for genome editing - Nature

Delivery technologies for genome editing Nature

Trends in clinical trial design complexity - Nature

Trends in clinical trial design complexity Nature

Calls grow to tap the gold mine of human genetic knockouts - Nature

Calls grow to tap the gold mine of human genetic knockouts Nature

Clinical trial cycle times continue to increase despite industry efforts - Nature

Clinical trial cycle times continue to increase despite industry efforts Nature

Advances in islet encapsulation technologies - Nature

Advances in islet encapsulation technologies Nature

Emerging applications of metabolomics in drug discovery and precision medicine - Nature

Emerging applications of metabolomics in drug discovery and precision medicine Nature

Trends in clinical success rates - Nature

Trends in clinical success rates Nature

Drug development in the era of precision medicine - Nature

Drug development in the era of precision medicine Nature

Identification and validation of biomarkers for autism spectrum disorders - Nature

Identification and validation of biomarkers for autism spectrum disorders Nature

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies - Nature

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies Nature

Ten years of anti-vascular endothelial growth factor therapy - Nature

Ten years of anti-vascular endothelial growth factor therapy Nature

Constrained peptides' time to shine? - Nature

Constrained peptides' time to shine? Nature

Integrin-based therapeutics: biological basis, clinical use and new drugs - Nature

Integrin-based therapeutics: biological basis, clinical use and new drugs Nature

Drug repurposing: progress, challenges and recommendations - Nature

Drug repurposing: progress, challenges and recommendations Nature

GDF15 tells the brain to lose weight - Nature

GDF15 tells the brain to lose weight Nature

What went wrong at Frisch's? Experts point to ownership change and asset sales - WCPO 9 News

What went wrong at Frisch's? Experts point to ownership change and asset sales WCPO 9 News

Pursuit of a perfect insulin - Nature

Pursuit of a perfect insulin Nature

How your pension works - USS pension

How your pension works USS pension

NRD Capital acquires Mike’s Kitchen - IOL

NRD Capital acquires Mike’s Kitchen IOL

Sport, Arts and Culture leads National Recreation Day and Big Walk in Mbombela and Tshwane - dsac.gov.za

Sport, Arts and Culture leads National Recreation Day and Big Walk in Mbombela and Tshwane dsac.gov.za

Mike’s Kitchen plans big return in South Africa - businesstech.co.za

Mike’s Kitchen plans big return in South Africa businesstech.co.za

Substitute teachers needed in public schools – here’s how to apply - businesstech.co.za

Substitute teachers needed in public schools – here’s how to apply businesstech.co.za

Top National Risk Distribution Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant